Immunohistochemical (IHC) staining was performed on bone marrow biopsy specimens obtained from patients above showed that PLXNB2 protein expression were significantly higher in patients with AML, particularly in patients with AML presenting with EMI (Fig. 1a, b). The gene discussed is PLXNB2; the disease is acute myeloid leukemia.